REGN icon

Regeneron Pharmaceuticals
REGN

Upgrade to unlock
Buy
Hold
Sell

13 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$803
6% upside
High target

13 analyst ratings

positive
5  neutral
38%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Truist Securities
Truist Securities
Gregory Renza
50% 1-yr REGN win rate
8 Jan ‘26 6 days ago
BofA Securities
BofA Securities
Tazeen Ahmad
0% 1-yr REGN win rate
7 Jan ‘26 7 days ago
Morgan Stanley
Morgan Stanley
Matthew Harrison
83% 1-yr REGN win rate
12 Dec ‘25 1 month ago
Wells Fargo
Wells Fargo
Mohit Bansal
100% 1-yr REGN win rate
10 Dec ‘25 1 month ago
Canaccord Genuity
Canaccord Genuity
John Newman
60% 1-yr REGN win rate
4 Dec ‘25 1 month ago
BMO Capital
BMO Capital
Evan Seigerman
75% 1-yr REGN win rate
4 Dec ‘25 1 month ago
Scotiabank
Scotiabank
Louise Chen
24 Nov ‘25 1 month ago
HSBC
HSBC
Yifeng Liu
0% 1-yr REGN win rate
24 Nov ‘25 1 month ago
UBS
UBS
Trung Huynh
7 Nov ‘25 2 months ago
Citigroup
Citigroup
Geoff Meacham
75% 1-yr REGN win rate
29 Oct ‘25 2 months ago
RBC Capital
RBC Capital
Brian Abrahams
50% 1-yr REGN win rate
29 Oct ‘25 2 months ago
Cantor Fitzgerald
Cantor Fitzgerald
Carter Gould
100% 1-yr REGN win rate
29 Oct ‘25 2 months ago
Guggenheim
Guggenheim
Yatin Suneja
67% 1-yr REGN win rate
29 Oct ‘25 2 months ago
BofA Securities
BofA Securities
Tim Anderson
0% 1-yr REGN win rate
29 Oct ‘25 2 months ago